Nutex Health Inc. operates as a physician-led healthcare services and operations company with a Hospital Division and a Population Health Management Division. Its hospital operations own, develop and operate micro-hospitals, specialty hospitals and hospital outpatient departments, while the population health business owns provider networks such as independent physician associations and provides management and administrative support through a management services organization.
Company news commonly covers quarterly and annual financial results, hospital openings and reopenings, expansion of facility operations across states, risk-bearing physician network activity, real estate-backed hospital development, earnings calls, healthcare conference participation and common stock repurchase authorizations.
Nutex Health (NUTX) reported third-quarter 2026 attributable net income of $40.2 million, down from the same quarter a year earlier. Diluted earnings per share fell to $5.71 from $7.76, while revenue decreased 18.7% to $217.6 million. Hospital visits rose 18.1%, but same-hospital revenue declined 20.1%. Operating cash flow fell to $78.3 million from $99.5 million.
For the nine months ended September 30, 2026, attributable net income increased 159% to $152.9 million, while revenue fell 10.9% to $644.9 million. Lower stock-based compensation primarily drove the earnings increase. A $52.3 million non-cash expense reduction also increased attributable net income by $25.0 million. Nine-month operating cash flow reached $188.1 million. Cash totaled $249.9 million, versus $185.6 million at year-end 2025; long-term debt, net, rose to $34.2 million from $29.2 million. The company expects two hospital openings in the fourth quarter.
Nutex Health (NUTX) plans to release its third-quarter financial results after market close on Nov. 5, 2026. The company also plans to file its Form 10-Q for the quarter ended Sept. 30, 2026, that day.
An earnings conference call is scheduled for Nov. 6, 2026, at 9:30 a.m. CT to discuss financial performance and provide a business update. A transcript and recording will be available afterward on the company website under Investor Materials.
Nutex Health (NUTX) has received approval to dual-list its common stock on Nasdaq Texas, with trading expected to begin on or about September 23, 2026. The shares will continue to trade on the Nasdaq Global Market under the ticker “NUTX,” and the dual listing does not require any action from existing stockholders. The company states that shares of common stock will remain fully fungible across both trading venues. Nutex Health describes the Nasdaq Texas listing as a way to expand its visibility among regional institutional investors while maintaining its national and international presence. In connection with the dual listing, a registration statement on Form 8-A has been filed with the U.S. Securities and Exchange Commission under Section 12(b) of the Securities Exchange Act of 1934.
Nutex Health (NUTX) reports that a third party has published data allegedly obtained in its previously disclosed cybersecurity incident.
The company and its external cybersecurity experts are downloading, processing and analyzing the posted data to determine its contents, scope and authenticity, a process expected to take several weeks due to the data volume. Nutex Health states that so far it has not identified any material impact on business operations or financial reporting systems, and its assessment of the incident's materiality remains unchanged from its August 31, 2026 Form 8-K. The company is evaluating regulatory and legal notification requirements, plans to notify affected patients and employees as required, and notes that several purported class action complaints related to the incident have been filed in federal court.
Nutex Health (NASDAQ: NUTX) reported multiple community-based awards for its hospitals in the second quarter of 2026. Facilities in Albuquerque, Green Bay, Milwaukee, Royse City, Topeka, West Plano and Wylie were honored in local community and readers’ choice programs, spanning categories such as best ER, best hospital finalist, and best place to work.
Nutex Health (NASDAQ: NUTX)/b) commented on an Aug. 11, 2026 en banc ruling by the U.S. Court of Appeals for the Fifth Circuit that invalidated key federal rules for calculating the qualifying payment amount (QPA) under the No Surprises Act. The court rejected use of non‑negotiated “ghost rates” and held that excluding bonus and incentive payments from QPA calculations conflicted with the statute’s “total maximum payment” standard, while upholding exclusion of single‑case agreements. Nutex Health said prior QPA methods had depressed out‑of‑network payments, forcing frequent use of the Independent Dispute Resolution (IDR) process, where certified entities selected payment amounts above the insurer QPA in about 85% of decided cases. Patient balance‑billing protections remain unchanged. The company noted that new agency rules, their timing, and the ultimate financial impact are uncertain, and current enforcement relief allows prior QPA methodologies for services furnished before October 1, 2026.
Nutex Health (NASDAQ: NUTX) announced the opening of West Little Rock Emergency Hospital, its 28th hospital nationwide and third in Arkansas, located at 17810 Chenal Parkway in Little Rock. The 18,966-square-foot facility offers eight emergency beds, five inpatient suites, two triage rooms, and a full-service lab with advanced imaging. According to Nutex Health, the new site expands access to 24/7 emergency and concierge-level care in the Little Rock metropolitan area.
Nutex Health (NASDAQ: NUTX) reported Q2 2026 net income attributable to Nutex of $65.8 million, or diluted EPS of $9.38, versus a $17.7 million loss a year earlier. For the first six months of 2026, net income attributable to Nutex rose to $112.6 million and diluted EPS to $15.87.
Six‑month revenue declined 6.3% year over year to $427.2 million, with Q2 revenue down 13.6% to $210.8 million, largely reflecting unusually strong IDR-related results in early 2025. EBITDA for the first half increased to $162.5 million and Adjusted EBITDA to $147.5 million. Operating income for the six months rose to $203.0 million from $114.3 million, while net cash from operating activities increased to $109.7 million. Hospital Division visits grew 9.6% in Q2 to 49,962 and 6.2% to 99,704 for the first half.
A June 30, 2026 amendment to the HaloMD agreement and a CMS fee reduction drove a $52.3 million cut in contract services expense. Nutex ended June 30, 2026 with $205.2 million in cash and $31.1 million in long‑term debt and plans to open three new hospitals later in 2026.
Nutex Health (NASDAQ: NUTX) plans to file its Form 10-Q for the second quarter ended June 30, 2026, on Thursday, Aug. 6, 2026, after market close, and issue a financial results release the same day.
The company will host an earnings conference call on Friday, Aug. 7, 2026, at 9:30 a.m. CT, with participant dial-in numbers and a Call me™ link provided, and will later post a transcript and recording under “Investor Materials” on its website.
Nutex Health (NASDAQ: NUTX) reported Q1 2026 results for the quarter ended March 31, 2026: total revenue $216.5M (up 2.2% year-over-year), net income attributable $46.8M (diluted EPS $6.52), EBITDA $68.3M, Adjusted EBITDA $57.6M, and operating cash flow $75.5M. Cash and cash equivalents totaled $207.3M and long-term debt, net declined to $24.3M. Hospital division visits increased 3.1% and same-hospital revenue rose 0.2%.